Inicio
Este sitio está destinado a profesionales de la salud.

Vías de atención para la apnea obstructiva del sueño: cómo traducir el riesgo cardiometabólico en un manejo longitudinal: Módulo 4. Manejo sostenido

Compartir

Descripción

Esta actividad cuenta con el apoyo de una subvención educativa independiente de Lilly. Este programa educativo en línea ha sido diseñado para profesionales de la salud en los Estados Unidos.

El Dr. Kirsch ofrece un marco práctico y longitudinal para el manejo a largo plazo de la AOS, haciendo hincapié en la necesidad de tratar la obstrucción de las vías respiratorias y la obesidad como objetivos clínicos interrelacionados. Este módulo se enfoca en resolver los obstáculos físicos y psicológicos tempranos que impiden la terapia de presión positiva en las vías respiratorias (PAP) y en programar seguimientos proactivos y compartidos para mantener la adherencia del paciente y mejorar los parámetros cardiometabólicos con el tiempo.

Puntos destacados de la sesión: ¿Quiénes deberían participar?

  • Implementar un marco de atención longitudinal que integre terapias dirigidas a las vías respiratorias con el seguimiento continuo de los parámetros cardiometabólicos, incluyendo la evolución del peso, la presión arterial y el control glucémico.
  • Resolver las barreras tempranas a la terapia de presión positiva en las vías respiratorias (PAP) programando controles cada 2 a 6 semanas para resolver problemas de ajuste del equipo, sequedad o ansiedad antes de que los pacientes abandonen el tratamiento.

Este programa está diseñado para profesionales de la salud que buscan incorporar la detección estructurada del SAOS y la activación diagnóstica en los flujos de trabajo de manejo cardiometabólico de rutina. Este es el módulo cuatro de seis; consulte los módulos 1, 2, 3, 5 y 6 aquí.

  • Médicos de atención primaria y especialistas en medicina familiar
  • Enfermeras practicantes
  • Asistentes médicos

¿Prefieres leer? Consulta nuestro resumen clínico clave aquí.

Cuerpo docente

Dr. Douglas Kirsch

El Dr. Douglas Kirsch es director médico de Medicina del Sueño en Atrium Health y profesor de Medicina Interna y Neurología. Como especialista certificado en medicina del sueño, cuenta con una amplia experiencia en el diagnóstico y manejo de los trastornos del sueño, con un enfoque de investigación particular en la apnea obstructiva del sueño (AOS). Su investigación examina el impacto del tratamiento de la AOS en las hospitalizaciones de los pacientes y explora el uso de dispositivos portátiles de consumo para evaluar el sueño en el entorno doméstico. El Dr. Kirsch es expresidente de la Academia Estadounidense de Medicina del Sueño y se dedica a mejorar la salud del sueño y el bienestar de los pacientes.

Divulgaciones

Partners for Advancing Clinical Education (Partners) exige que toda persona en posición de controlar el contenido educativo divulgue todas las relaciones financieras con empresas no elegibles que hayan tenido lugar en los últimos 24 meses. Las empresas no elegibles son aquellas cuya actividad principal consiste en producir, comercializar, vender, revender o distribuir productos de salud utilizados por o en pacientes. Todas las relaciones financieras relevantes se mitigan de acuerdo con las políticas de Partners.

A continuación se enumeran todas las relaciones financieras relevantes de cualquier persona con capacidad para controlar el contenido de esta actividad educativa, las cuales han sido mitigadas de acuerdo con las políticas de Partners. Las demás personas involucradas en la planificación de esta actividad no tienen relaciones financieras relevantes.

El Dr. Douglas Kirsch, miembro del cuerpo docente de esta actividad educativa, tiene las siguientes relaciones financieras relevantes: Consejo Asesor Científico: Apnimed, Incannex, Huxley Medical. Panel de expertos: Carelon. Consultoría: ResMed.

El personal de MedAll, los planificadores del programa y los revisores no tienen relaciones financieras relevantes con empresas no elegibles que deban divulgarse.

Declaración conjunta de acreditación

Con el fin de mejorar la atención al paciente, esta actividad ha sido planificada e implementada por Partners for Advancing Clinical Education (Partners) y MedAll. Partners cuenta con la acreditación conjunta del Consejo de Acreditación para la Educación Médica Continua (ACCME), el Consejo de Acreditación para la Educación Farmacéutica (ACPE) y el Centro Estadounidense de Acreditación de Enfermeras (ANCC), para brindar educación continua al equipo de salud.

Educación continua para médicos

Partners establece que esta actividad permanente tendrá una duración máxima de 0,25 créditos AMA PRA Categoría 1™. Los médicos deben solicitar únicamente los créditos correspondientes al grado de su participación en la actividad.

Educación continua para asistentes médicos

Partners ha sido autorizada por la Academia Estadounidense de Asistentes Médicos (AAPA) para otorgar créditos de CME de Categoría 1 de la AAPA por actividades planificadas de acuerdo con los criterios de CME de la AAPA. Esta actividad está designada para otorgar 0,25 créditos de CME de Categoría 1 de la AAPA.

Los asistentes médicos (PA) deben solicitar únicamente los créditos correspondientes al grado de su participación.

Desarrollo profesional continuo para enfermería

El número máximo de horas otorgadas para esta actividad de desarrollo profesional continuo para enfermería es de 0,25 horas de contacto de la ANCC.

Divulgación de usos no indicados en la etiqueta

Esta actividad educativa puede incluir discusiones sobre usos publicados y/o en investigación de agentes que no están indicados por la FDA. Los organizadores de esta actividad no recomiendan el uso de ningún agente fuera de las indicaciones autorizadas. Las opiniones expresadas en la actividad educativa son las del cuerpo docente y no representan necesariamente los puntos de vista de los organizadores. Consulte la información oficial de prescripción de cada producto para conocer las indicaciones, contraindicaciones y advertencias aprobadas.

Descargo de responsabilidad

Los participantes tienen la responsabilidad implícita de utilizar la información recién adquirida para mejorar los resultados de los pacientes y su propio desarrollo profesional. La información presentada en esta actividad no pretende servir como guía para el manejo de pacientes. Los médicos no deben utilizar ningún procedimiento, medicamento u otro método de diagnóstico o tratamiento discutido o sugerido en esta actividad sin evaluar el estado de sus pacientes y las posibles contraindicaciones y/o riesgos de uso, sin revisar la información del producto del fabricante correspondiente y sin compararla con las recomendaciones de otras autoridades.

Información sobre cuotas

Esta actividad educativa es gratuita.

Esta actividad de educación continua estará vigente a partir del 14 de octubre de 2026 y vencerá el 1 de julio de 2028.

Objetivos de aprendizaje

1: Evaluar la relación bidireccional entre la obesidad y la AOS para orientar la evaluación del riesgo cardiometabólico, demostrando una identificación precisa del riesgo de AOS en al menos el 75 % de las evaluaciones basadas en casos posteriores a la actividad.

2: Identificar a los pacientes con mayor riesgo de AOS utilizando características clínicas y comorbilidades en la atención primaria, logrando una estratificación adecuada del riesgo en al menos el 75 % de los escenarios clínicos aplicados.

3: Aplicar estrategias de detección y triaje compatibles con el flujo de trabajo para apoyar la identificación temprana de la AOS, demostrando el uso correcto de herramientas estructuradas y vías de decisión en al menos el 75 % de los ejercicios basados en simulaciones.

4: Seleccionar vías de diagnóstico y derivación adecuadas, incluyendo la HSAT, basadas en la presentación clínica y el contexto de la práctica, logrando la activación adecuada de las vías en al menos el 75 % de las evaluaciones basadas en casos.

5: Aplicar estrategias de manejo longitudinal y de progresión del tratamiento en la planificación de la atención de la AOS para apoyar el control sostenido de la enfermedad, demostrando una toma de decisiones adecuada en al menos el 70 % de los ejercicios de casos longitudinales.

6: Aplicar estrategias de atención adaptadas al contexto que tengan en cuenta los factores socioeconómicos y del entorno de la práctica para apoyar decisiones equitativas de diagnóstico y manejo de la AOS, demostrando una toma de decisiones adecuada en al menos el 70 % de los escenarios aplicados.

Comunidades similares

Ver todo

Eventos y vídeos bajo demanda similares

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

This next section is on sustained management of patients with obstructive sleep apnea. So we've talked about evaluating the potential for patients to have sleep apnea. We've talked about how you assess patients for sleep apnea with sleep studies, and now we're going to talk about treating patients and how you do that in the long term. So it's important to recognize that when you see patients, you have to manage two sides of the spectrum. One is how am I managing their sleep apnea and whether that's with CPAP or PAP therapy, but also with other possibilities such as positional therapy, surgical options, or oral appliances. And you sometimes have to deal in patients who are obese with the obesity side of this and their cardio metabolic care, so their weight, their BP, their Blood sugars, their cardiovascular risk. And so putting that together, you are trying to make sure you understand what are their current symptoms, how adherent are they to therapy, whether obstructive sleep apnea therapy or their um therapy for their cardio metabolic symptoms. How tolerable is that therapy? What are their goals, and what are reasons to escalate this to a higher level and potentially to have them see a specialist. So we have to manage both of these things over time as best we can knowing that time is limited. So let's talk about this a little bit and what that framework might look like. So, if you start somebody on path therapy, the most important thing is having patients understand why they are getting that treatment and why that treatment is important. Too often patients do not get told why they need a CPAP machine, and they are much less likely to use a CPAP machine if they don't understand the reasoning for it. So explaining to patients why they need a machine and why it's important to use it is a first step towards success. And then the second most important part is the education around getting the machine and the early follow-up. So when they get a machine, helping them understand how to select the right kind of CPAP mask, what the pressure settings should be on their CPAP machine. And making sure they have that early support either from your clinic or from the home medical equipment company is crucial to make a patient successful because we know that if we can intervene with problems early, particularly in the 1st 2 to 4 weeks, a patient is much more likely to be adherent in the long run than if they don't come back and see somebody for 3 or 4 months, at which point they've often already given up. What are some of the things that you think about in that early phase? Well, it's about mask fit. It's about making sure that their pressure is comfortable for them, making sure that they're getting appropriate humidification from their CPAP machine, um, and that they're just using it every night. I tell patients that it is the most important thing to start every night with it. They may take it off in the middle of the night. They may struggle to keep it on. They may wake up and it's off and they don't remember taking it off. But if they start each night with it, it is much more likely that they're going to be able to get comfortable with it, particularly in that 1st 2 to 4 weeks. How do we assess how they're doing? Well, part of it is based on the patient's report of their symptoms, but part of it is also getting data back from their CPAP machine to make sure that they're using it appropriately and that it's doing what we expect it to do, that in fact their sleep apnea appears controlled. Understanding what their experience is there is crucial because even at that 3 month review, assuming you were meeting with that patient, there are still some subtle tweaks that can often be made to make that patient's experience just a little bit better and we know each click along that way that we can make that experience better is going to keep that patient on therapy longer. And then continuing to treat over time to make sure that they are doing well. This requires follow up in my clinic. It's usually we will see them back at 3 months, 6 months, and a year in the first year, and then assuming they're doing well yearly thereafter, but every clinic may do things slightly differently. So what do you do if a pap therapy isn't working for a patient? Well, the first problem is trying to figure out Whether a patient's having a problem or not, how do you do that? Well, A couple of things. One is, is a patient feeling any better? The answer may be yes or no. Um, and if the case is I'm not feeling better, are you using treatment? The second thing is, is a patient just stopped using it or using it as regularly and what has been a problem there? Sometimes patients just drop off for a few days when they get sick, but sometimes they drop off and then they never pick it back up again. And so it's important to make sure that you're tracking that data every so often. Again, hoping that you're getting some help from your uh durable medical equipment company who has provided that patient a CPAP machine. And then tracking that data to make sure that there aren't residual apnea still on. While the patient is using CPAP, that is a sign of a problem, and you want to make sure that that is being addressed. Now if that data is mildly abnormal, you might not be particularly prone to trying to make the patient much more uncomfortable on their CPAP by changing the pressure settings. On the other hand, if it's significantly abnormal, you might choose to be more aggressive about that. So, once you find that there's a problem, talk to the patient. That's the best source of the information. Is this a mask issue? Is this a pressure issue? Is this a dryness issue? Is it nasal congestion that's a problem? Are you having anxiety or difficulty sleeping with the CPAP in place? Is cost a problem? Is this gonna be an issue of, hey, I don't think this is really working for me? And sometimes they just need to give it more time. Patients often expect that this will be effective day one. And I often tell people that it can take 2 to 4 weeks just to get used to the mask and the machine, and then it may be that you don't feel better for 2 or 3 months. That's why that 3 month time frame is really important to check back in with patients. And then the question is, well, once you've identified that there's a problem and you've figured out what the problem is, now how can I fix it? Well, can you fix it yourself? Is there a barrier you can change or tweak to make that patient easier? Is that a, hey, let me just reinforce the importance of this. Let me just make sure that your settings look correct and remind you that using a machine is is an important treatment for your sleep apnea. But sometimes you're not going to be able to do that on your own, and escalating care to a sleep specialist can be helpful at this point. And that may be to reassess whether the diagnosis is a good one. Was the test a fair test of their sleep apnea initially, and are you treating the right thing? Could they have central sleep apnea? Is the CPAP a right treatment? Could they need a BiPAP machine? All these things are possible. And so making sure that you get a specialist involved in some cases can be helpful. So to summarize this slide, just make sure that once you start the process, you figure out how you can address it and then reassess after you've made a change to make sure that you've in fact the patient has found improvement from whatever you've done, whether that's from data or patient experience. These are the steps to think. If the patient has really struggled with PAP therapy and it is not an option for them at that point, would you consider other treatments of sleep apnea for them, whether that's an oral appliance, whether that's positional strategies, whether that's surgical intervention, or continuing to work on weight in a more intensive way? So weight treatment alone Can be part, should be part of sleep apnea care in those who are obese. And so we know that as we drop weight in patients, that their AHI is likely to improve, as you can see in the graph here on the slide. The more weight they lose, the lower the AHI tends to be. Now just because somebody has lost weight doesn't mean that their sleep apnea is necessarily resolved. And so it is important to consider once somebody has stabilized at a new weight to reassess the situation from a sleep apnea severity perspective. How do you get that weight to be uh lower? Well, I would say a few things. One, Working with patients on diet and exercise has been a classic part of visits for patients for years. But again, sometimes you can't do this on your own. And whether that's working with a dietitian or nutritionist, whether that's working with behavioral health, whether it's looking at pharma uh pharma the pharmacology of the drugs that they are currently on, or whether a new drug needs to be added, or whether there's a bariatric pathway that is important for that patient and working with weight management.